D
Neurothera Labs Inc. NTLX.V
TSX
Recommendation
Dividend Power Score
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 12/31/2024
Total Cash And Short-Term Investments 2,295.77% --
Total Receivables -12.50% --
Inventory -16.67% --
Prepaid Expenses -- --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets 0.00% --
Total Current Assets 619.31% --

Total Current Assets 619.31% --
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -12.36% --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets -- --
Total Assets 90.28% --

Total Accounts Payable 2,561.54% --
Total Accrued Expenses 281.61% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities 1,811.11% --
Total Other Current Liabilities 1,811.11% --
Total Current Liabilities 1,067.80% --

Total Current Liabilities 1,067.80% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 112.38% --
Total Liabilities 645.31% --

Common Stock & APIC 351.16% --
Retained Earnings -482.05% --
Treasury Stock & Other -- --
Total Common Equity -89.48% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity -89.48% --
Total Preferred Equity -- --
Total Minority Interest -- --
Total Equity -49.14% --